Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition) ›› 2018, Vol. 04 ›› Issue (01): 29-32. doi: 10.3877/cma.j.issn.2096-0263.2018.01.007

Special Issue:

• Hip Fracture Combine with Heart Failure • Previous Articles     Next Articles

Effectivness study of Leosimendan in the treatment of perioperative in elderly hip fracture with heart failure

Yafeng Hao1, Yuan Li2,(), Zhiqian Wang3, Wenyong Ji4, Xudong Wang5   

  1. 1. Department of Cardiology, the First Hospital of Handan, Handan 056002, China
    2. Department of Internal Medicine, the Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
    3. Department of Cardiology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China
    4. Department of Cardiology, the Chinese Hospital of Chengan, Handan 056002, China
    5. Department of Orthopedics, the First Hospital of Handan, Handan 056002, China
  • Received:2017-06-20 Online:2018-02-05 Published:2018-02-05
  • Contact: Yuan Li
  • About author:
    Corresponding author: Li Yuan, Email:

Abstract:

Objective

To study the effect of levosimendan in the treatment of elderly heart failure patients underwent urgent hip fracture repairment.

Methods

A retrospective analysis was performed in the First Hospital of Handan from January 2013 to December 2016, including 64 (30 femoral neck fracture, 34 intertrochanteric fracture) elderly hip fractures conforming to inclusion criteria. Patients were divided into levosimendan group and control group according to the application of levosimendan, the levosimendan group had 32 cases same as the control group. The left ventricular ejection fraction (LVEF), b-type natriuretic peptide (BNP) and cardiac output (CO), cardiac index (CI) before application of levosimendanat 24 h and 7 d after surgery were compared to evaluate the curative effect of levosimendan.

Results

LVEF, CO, CI at 24 h and 7 d after syrgery in Leosimendan group were significantly higher than control group (LVEF: t=2.428, t=3.150; CI: t=3.349, t=3.777; CO: t=2.615, t=2.620, P<0.05), BNP levels at 24 h and 7 d after surgery in leosimendan group was significantly lower than the control group, with statistical significance (t=2.989, t=2.693, P<0.05).

Conclusion

Levosimendan can be used to improve heart function and prognosis of elderly hip fracture with heart failure by regulating perioperative hemodynamic index.

Key words: Hip fractures, Aged, Simendan, Heart failure

京ICP备07035254号-18
Copyright © Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), All Rights Reserved.
Tel: 0311-88603818 E-mail: zhlngkykf@126.com
Powered by Beijing Magtech Co. Ltd